Skip to content
10-Q

Quarterly Report

Praxis Precision Medicines, Inc. PRAX

0001689548-26-000047

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 27.88M sh
Shares Diluted Q1 2026 · Mar 31, 2026 28.88M sh
Shares Diluted Q1 2026 · Mar 31, 2025 21.06M sh
Capex Q1 2026 · Mar 31, 2026 $62K
Capex Q1 2026 · Mar 31, 2025 $0
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$86.15M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$53.01M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $536.33M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $357.33M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $165.57M
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.41B
Stockholders Equity Q1 2026 · Dec 31, 2025 $878.14M
Stockholders Equity Q1 2026 · Mar 31, 2025 $439.21M
Stockholders Equity Q1 2026 · Dec 31, 2024 $445.45M
Current Liabilities Q1 2026 · Mar 31, 2026 $50.24M
Current Liabilities Q1 2026 · Dec 31, 2025 $59.77M
Total Liabilities Q1 2026 · Mar 31, 2026 $50.24M
Total Liabilities Q1 2026 · Dec 31, 2025 $59.77M
Current Assets Q1 2026 · Mar 31, 2026 $797.77M
Current Assets Q1 2026 · Dec 31, 2025 $610.91M
Total Assets Q1 2026 · Mar 31, 2026 $1.46B
Total Assets Q1 2026 · Dec 31, 2025 $937.91M
Eps Diluted Q1 2026 · Mar 31, 2026 −$3.20
Eps Diluted Q1 2026 · Mar 31, 2025 −$3.29
Eps Basic Q1 2026 · Mar 31, 2026 −$3.20
Eps Basic Q1 2026 · Mar 31, 2025 −$3.29
Sga Expense Q1 2026 · Mar 31, 2026 $27.87M
Sga Expense Q1 2026 · Mar 31, 2025 $13.92M
Rd Expense Q1 2026 · Mar 31, 2026 $77.99M
Rd Expense Q1 2026 · Mar 31, 2025 $60.81M
Net Income Q1 2026 · Mar 31, 2026 −$92.56M
Net Income Q1 2026 · Mar 31, 2025 −$69.3M
Operating Income Q1 2026 · Mar 31, 2026 −$105.86M
Operating Income Q1 2026 · Mar 31, 2025 −$74.73M